118th Congress · HOUSE BILLBILL

H.R. 2707MADE in America Act

To mitigate drug shortages and provide incentives for maintaining, expanding, and relocating the manufacturing of active pharmaceutical ingredients, excipients, medical diagnostic devices, pharmaceuticals, and personal protective equipment in the United States, and for other purposes.

Health
Introduced Apr 19, 2023
Last action Dec 17, 2024
Pipeline · Bill → Law
Step 1
Introduced
Apr 19, 2023
Step 2
Referred
Dec 17, 2024
Ways & Means
Step 3
Committee
Step 4
House floor
Step 5
Senate
Step 6
Resolve Changes
Step 7
Signed
SummaryCRS Summary

This bill establishes a tax credit for certain manufacturers of pharmaceuticals or medical products. Specifically, the bill establishes a tax credit for manufacturers of pharmaceuticals, active pharmaceutical ingredients, excipients (i.e., inactive ingredients), medical diagnostic devices, or personal protective equipment, if they are located in a designated distressed zone. The tax credit is equal to 25% of the manufacturer's production expenditures; the credit increases to 30% of expenditures if a substantial portion of the manufacturer's employees reside in a distressed zone. The bill defines distressed zone as an area that has been designated as a qualified opportunity zone by the Inte...

Provisions · 2 sectionsIntroduced in House
Timeline · 3 actions
Dec 17, 2024
Referred to the Subcommittee on Health.
Apr 19, 2023
Introduced in House
Apr 19, 2023
Referred to the House Committee on Ways and Means.